Cargando…

A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT(1A) receptor antagonist and SSRI in rats

Lifelong premature ejaculation (PE) in men lacks an adequate on-demand pharmacological treatment. Although selective serotonin reuptake inhibitors (SSRIs) are used for PE they only work after chronic treatment, or if used on-demand, less adequately than chronic SSRI treatment. It has been shown that...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivier, Jocelien D. A., Janssen, Josien A., Esquivel-Franco, Diana C., de Prêtre, Stephen, Olivier, Berend
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534979/
https://www.ncbi.nlm.nih.gov/pubmed/37781259
http://dx.doi.org/10.3389/fnins.2023.1224959
_version_ 1785112522436640768
author Olivier, Jocelien D. A.
Janssen, Josien A.
Esquivel-Franco, Diana C.
de Prêtre, Stephen
Olivier, Berend
author_facet Olivier, Jocelien D. A.
Janssen, Josien A.
Esquivel-Franco, Diana C.
de Prêtre, Stephen
Olivier, Berend
author_sort Olivier, Jocelien D. A.
collection PubMed
description Lifelong premature ejaculation (PE) in men lacks an adequate on-demand pharmacological treatment. Although selective serotonin reuptake inhibitors (SSRIs) are used for PE they only work after chronic treatment, or if used on-demand, less adequately than chronic SSRI treatment. It has been shown that the addition of a behaviorally silent 5-HT(1A)–receptor antagonist to an SSRI can generate acute inhibitory effects on male rat sexual behavior. Atlas987 is a selective 5-HT(1A)-receptor antagonist with equal potency to displace agonist and antagonist binding to pre- and post-synaptic 5-HT(1A) receptors in rat and human brain. To investigate whether Atlas987 together with the SSRI paroxetine, a combination called Enduro, induces acute inhibitory effects on male rat sexual behavior, we tested Enduro in Wistar rats in a dose-dependent manner. We first tested the 5-HT(1A) receptor antagonist Atlas987 in 8-OH-DPAT induced serotonergic behavior in rats. Second, we tested Enduro in a dose-dependent manner in male sexual behavior. Third, we tested the effective time window of Enduro’s action, and lastly, we measured the plasma levels of Atlas987 and paroxetine over an 8-h period. Results showed that Enduro acutely and dose-dependently reduced the number of ejaculations and increased the ejaculation latencies. The behavioral pattern induced reflected a specific effect on sexual behavior excluding non-specific effects like sedation or sensoric-motoric disturbances. The time-window of activity of Enduro showed that this sexual inhibitory activity was at least found in a 1–4 h’ time window after administration. Plasma levels showed that in this time frame both Atlas987 and paroxetine are present. In conclusion, in rats, Enduro is successful in acutely inhibiting sexual behavior. These results may be therapeutically attractive as “on demand” treatment for life-long premature ejaculation in men.
format Online
Article
Text
id pubmed-10534979
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105349792023-09-29 A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT(1A) receptor antagonist and SSRI in rats Olivier, Jocelien D. A. Janssen, Josien A. Esquivel-Franco, Diana C. de Prêtre, Stephen Olivier, Berend Front Neurosci Neuroscience Lifelong premature ejaculation (PE) in men lacks an adequate on-demand pharmacological treatment. Although selective serotonin reuptake inhibitors (SSRIs) are used for PE they only work after chronic treatment, or if used on-demand, less adequately than chronic SSRI treatment. It has been shown that the addition of a behaviorally silent 5-HT(1A)–receptor antagonist to an SSRI can generate acute inhibitory effects on male rat sexual behavior. Atlas987 is a selective 5-HT(1A)-receptor antagonist with equal potency to displace agonist and antagonist binding to pre- and post-synaptic 5-HT(1A) receptors in rat and human brain. To investigate whether Atlas987 together with the SSRI paroxetine, a combination called Enduro, induces acute inhibitory effects on male rat sexual behavior, we tested Enduro in Wistar rats in a dose-dependent manner. We first tested the 5-HT(1A) receptor antagonist Atlas987 in 8-OH-DPAT induced serotonergic behavior in rats. Second, we tested Enduro in a dose-dependent manner in male sexual behavior. Third, we tested the effective time window of Enduro’s action, and lastly, we measured the plasma levels of Atlas987 and paroxetine over an 8-h period. Results showed that Enduro acutely and dose-dependently reduced the number of ejaculations and increased the ejaculation latencies. The behavioral pattern induced reflected a specific effect on sexual behavior excluding non-specific effects like sedation or sensoric-motoric disturbances. The time-window of activity of Enduro showed that this sexual inhibitory activity was at least found in a 1–4 h’ time window after administration. Plasma levels showed that in this time frame both Atlas987 and paroxetine are present. In conclusion, in rats, Enduro is successful in acutely inhibiting sexual behavior. These results may be therapeutically attractive as “on demand” treatment for life-long premature ejaculation in men. Frontiers Media S.A. 2023-09-13 /pmc/articles/PMC10534979/ /pubmed/37781259 http://dx.doi.org/10.3389/fnins.2023.1224959 Text en Copyright © 2023 Olivier, Janssen, Esquivel-Franco, de Prêtre and Olivier. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Olivier, Jocelien D. A.
Janssen, Josien A.
Esquivel-Franco, Diana C.
de Prêtre, Stephen
Olivier, Berend
A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT(1A) receptor antagonist and SSRI in rats
title A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT(1A) receptor antagonist and SSRI in rats
title_full A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT(1A) receptor antagonist and SSRI in rats
title_fullStr A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT(1A) receptor antagonist and SSRI in rats
title_full_unstemmed A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT(1A) receptor antagonist and SSRI in rats
title_short A new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-HT(1A) receptor antagonist and SSRI in rats
title_sort new approach to ‘on-demand’ treatment of lifelong premature ejaculation by treatment with a combination of a 5-ht(1a) receptor antagonist and ssri in rats
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534979/
https://www.ncbi.nlm.nih.gov/pubmed/37781259
http://dx.doi.org/10.3389/fnins.2023.1224959
work_keys_str_mv AT olivierjocelienda anewapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats
AT janssenjosiena anewapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats
AT esquivelfrancodianac anewapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats
AT depretrestephen anewapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats
AT olivierberend anewapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats
AT olivierjocelienda newapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats
AT janssenjosiena newapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats
AT esquivelfrancodianac newapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats
AT depretrestephen newapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats
AT olivierberend newapproachtoondemandtreatmentoflifelongprematureejaculationbytreatmentwithacombinationofa5ht1areceptorantagonistandssriinrats